financial guidance Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum." DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand The company said that its Q1 revenue growth was driven in part by SARS-CoV-2 test revenues of €102.0 million, booked mainly in the US, Canada, and Europe. Castle Biosciences Q1 Revenues Up 31 Percent The company said it delivered 11 percent fewer DecisionDx-Melanoma test results year over year, but that the total number of all tests delivered rose 4 percent. Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent Despite the overall revenue increase, revenues from Meridian's diagnostic segment were down 9 percent. Natera Q1 Revenues Grow 62 Percent The company reported $152.3 million in total revenues for the quarter and said the number of tests it processed rose 48 percent from the prior-year quarter. May 5, 2021 Personalis Q1 Revenues Grow 9 Percent May 5, 2021 CareDx Q1 Revenues up 76 Percent May 4, 2021 Exact Sciences Reports 16 Percent Q1 Revenues Rise, Acquires PFS Genomics for $30.6M May 4, 2021 PerkinElmer Q1 Revenues More Than Double on Strong Diagnostics Business May 3, 2021 Qiagen Q1 Revenues Jump 52 Percent Apr 22, 2021 Danaher Q1 Revenues Up 58 Percent Apr 21, 2021 Roche Diagnostics Q1 Sales Climb 50 Percent Apr 20, 2021 Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing Apr 15, 2021 Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire Apr 13, 2021 Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance Apr 5, 2021 Illumina Preliminary Q1 Revenues Grow 26 Percent Mar 25, 2021 Epigenomics Reports 24 Percent Drop in 2020 Revenues, Seeks Sale After Negative Coverage Decision Mar 18, 2021 Progenity Q4 Revenues Fall 30 Percent on COVID-19 Effect Mar 10, 2021 Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand Mar 4, 2021 T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales Mar 1, 2021 NanoString Technologies Q4 Revenues Fall 2 Percent Feb 25, 2021 Natera Revenues Grow 35 Percent in Q4 Feb 25, 2021 Berkeley Lights Q4 Revenues Rise 31 Percent Feb 25, 2021 GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.